» Articles » PMID: 28151851

True Rise in Anaphylaxis Incidence: Epidemiologic Study Based on a National Health Insurance Database

Overview
Specialty General Medicine
Date 2017 Feb 3
PMID 28151851
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence trend of anaphylaxis in Asia is not well investigated. The aim of this study is to estimate the entire population-based incidence of anaphylaxis in Korea using a nationwide administrative database.Data over a 7-year period (2008-2014) was obtained from the Korean National Health Insurance (NHI) claims database which covers 97.9% of the entire Korean population. Using diagnosis codes from the International Classification of Diseases-10 for anaphylaxis (T78.0, T78.2, T80.5, and T88.6), we identified the annual number of patients who had visited any hospital with a primary diagnosis of anaphylaxis. Incidence rates were calculated using the population distribution data of all NHI beneficiaries.The incidence of anaphylaxis in Korea was 32.19 episodes per 100,000 person-years in 2014, which nearly doubled from 2008 (16.02 episodes per 100,000 person-years). The incidence of anaphylaxis increased continuously throughout these years regardless of gender and age groups (P for trend < 0.001). Female was significantly less predisposed than male (adjusted odds ratio [OR], 0.69; 95% confident interval [CI], 0.66-0.72; P < 0.001). The incidence was the lowest in 0 to 19 age group and the highest in 40 to 69 age group (adjusted OR, 2.41; 95% CI, 2.29-2.54; P < 0.001).In conclusion, we report the increasing time trend of anaphylaxis incidence rates using nationwide claims database for the first time in Asia.

Citing Articles

The Application of Knowledge-Based Clinical Decision Support Systems to Detect Antibiotic Allergy.

Han N, Oh O, Oh J, Kim Y, Lee Y, Cha W Antibiotics (Basel). 2024; 13(3).

PMID: 38534679 PMC: 10967561. DOI: 10.3390/antibiotics13030244.


COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barré Syndrome, and mortality in South Korea using a nationwide population-based cohort study.

Jeong H, Chun B PLoS One. 2024; 19(2):e0297902.

PMID: 38381729 PMC: 10881009. DOI: 10.1371/journal.pone.0297902.


Population-based incidence of all-cause anaphylaxis and its development over time: a systematic review and meta-analysis.

Puhringer V, Jilma B, Herkner H Front Allergy. 2023; 4:1249280.

PMID: 38148907 PMC: 10749935. DOI: 10.3389/falgy.2023.1249280.


Contemporary trends in anaphylaxis burden and healthcare utilisation in Western Australia: A linked data study.

Stiles S, Sanfilippo F, Loh R, Said M, Clifford R, Salter S World Allergy Organ J. 2023; 16(9):100818.

PMID: 37780579 PMC: 10534263. DOI: 10.1016/j.waojou.2023.100818.


Positive Predictive Values of Anaphylaxis Diagnosis in Claims Data: A Multi-Institutional Study in Taiwan.

Chang C, Liao S, Shao S J Med Syst. 2023; 47(1):97.

PMID: 37695529 DOI: 10.1007/s10916-023-01989-2.


References
1.
Lieberman P, Camargo Jr C, Bohlke K, Jick H, Miller R, Sheikh A . Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006; 97(5):596-602. DOI: 10.1016/S1081-1206(10)61086-1. View

2.
Gupta R, Sheikh A, Strachan D, Anderson H . Time trends in allergic disorders in the UK. Thorax. 2006; 62(1):91-6. PMC: 2111268. DOI: 10.1136/thx.2004.038844. View

3.
Liew W, Williamson E, Tang M . Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009; 123(2):434-42. DOI: 10.1016/j.jaci.2008.10.049. View

4.
Lee J, Vadas P . Anaphylaxis: mechanisms and management. Clin Exp Allergy. 2011; 41(7):923-38. DOI: 10.1111/j.1365-2222.2011.03779.x. View

5.
Sheikh A, Alves B . Hospital admissions for acute anaphylaxis: time trend study. BMJ. 2000; 320(7247):1441. PMC: 27386. DOI: 10.1136/bmj.320.7247.1441. View